HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific

Biomedicine and Pharmacotherapy

Volumn 57, Issue 1, 2003, Pages 41-48

  Hogan, Tricia H ^a   Nonnemacher, Michael R ^a   Krebs, Fred C ^a   Henderson, Andrew ^b   Wigdahl, Brian ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

C EBP; HIV 1; LTR; Vpr

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CIS ACTING ELEMENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; VPR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BLOOD; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE PRODUCTS, VPR; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; OLIGONUCLEOTIDES; PROTEIN BINDING; SEQUENCE HOMOLOGY, NUCLEIC ACID; U937 CELLS;

EID: 0037225814     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(02)00333-5     Document Type: Article

References (31)

1. Agostini I., Navarro J.M., Rey F., Bouhamdan M., Spire B., Vigne R., et al. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J Mol Biol. 261:1996;599-606.
2. Antalis T.M., Godbolt D., Donnan K.D., Stringer B.W. Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2. Gene. 134:1993;201-208.
3. Ayyavoo V., Mahalingam S., Rafaeli Y., Kudchodkar S., Chang D., Nagashunmugam T., et al. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T-cells and monocytoid cells in vitro. J Leukoc Biol. 62:1997;93-99.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
5. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol. 64:1990;3097-3099.
6. Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206:1995;935-944.
7. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
8. Emerman M., Malim M.H. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science. 280:1998;1880-1884.
9. Estable M.C., Bell B., Merzouki A., Montaner J.S., O'Shaughnessy M.V., Sadowski I.J. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol. 70:1996;4053-4062.
10. Felzien L.K., Woffendin C., Hottiger M.O., Subbramanian R.A., Cohen E.A., Nabel G.J. HIV transcriptional activation by the accessory protein, Vpr, is mediated by the p300 co-activator. Proc Natl Acad Sci USA. 95:1998;5281-5286.
11. Garner M.M., Revzin A. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9:1981;3047-3060.
12. Goh W.C., Rogel M.E., Kinsey C.M., Michael S.F., Fultz P.N., Nowak M.A., et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat M. 4:1998;65-71.
13. Henderson A.J., Calame K.L. CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T-cells. Proc Natl Acad Sci USA. 94:1997;8714-8719.
14. Jowett J.B., Planelles V., Poon B., Shah N.P., Chen M.L., Chen I.S. The human immunodeficiency virus type 1 vpr gene arrests infected T-cells in the G2 + M phase of the cell cycle. J Virol. 69:1995;6304-6313.
15. Kashanchi F., Agbottah E.T., Pise-Masison C.A., Mahieux R., Duvall J., Kumar A., et al. Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator. J Virol. 74:2000;652-660.
16. Kirchhoff F., Greenough T.C., Hamacher M., Sullivan J.L., Desrosiers R.C. Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology. 232:1997;319-331.
17. Lu Y.L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol. 67:1993;6542-6550.
18. Mahalingam S., Collman R.G., Patel M., Monken C.E., Srinivasan A. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. Virology. 212:1995;331-339.
19. Mahalingam S., Khan S.A., Jabbar M.A., Monken C.E., Collman R.G., Srinivasan A. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. Virology. 207:1995;297-302.
20. McAllister J.J., Phillips D., Millhouse S., Conner J., Hogan T., Ross H.L., et al. Analysis of the HIV-1 LTR NF-κB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology. 274:2000;262-277.
21. Michael N.L., D'Arcy L., Ehrenberg P.K., Redfield R.R. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol. 68:1994;3163-3174.
22. Philippon V., Matsuda Z., Essex M. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx. J Hum Virol. 2:1999;167-174.
23. Ross H.L., Gartner S., McArthur J.C., Corboy J.R., McAllister J.J., Millhouse S., et al. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol. 7:2001;235-249.
24. Roux P., Alfieri C., Hrimech M., Cohen E.A., Tanner J.E. Activation of transcription factors NF-κB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J Virol. 74:2000;4658-4665.
25. Sawaya B.E., Khalili K., Rappaport J., Serio D., Chen W., Srinivasan A., et al. Suppression of HIV-1 transcription and replication by a Vpr mutant. Gene Ther. 6:1999;947-950.
26. Singh S.P., Lai D., Cartas M., Serio D., Murali R., Kalyanaraman V.S., et al. Epitope-tagging approach to determine the stoichiometry of the structural and non-structural proteins in the virus particles: amount of Vpr in relation to Gag in HIV-1. Virology. 268:2000;364-371.
27. Sundstrom C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 17:1976;565-577.
28. Vanitharani R., Mahalingam S., Rafaeli Y., Singh S.P., Srinivasan A., Weiner D.B., et al. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro. Virology. 289:2001;334-342.
29. Wang L., Mukherjee S., Jia F., Narayan O., Zhao L.J. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem. 270:1995;25564-25569.
30. Withers-Ward E.S., Jowett J.B., Stewart S.A., Xie Y.M., Garfinkel A., Shibagaki Y., et al. Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J Virol. 71:1997;9732-9742.
31. Zhang S., Pointer D., Singer G., Feng Y., Park K., Zhao L.J. Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene. 212:1998;157-166.